جستجو
Psychoactive Substances
Psychoactive substances are natural or synthetic substances that act on the central nervous system and alter mental processes such as mood, perception, cognition, consciousness, and behaviour. These substances may be legally prescribed medications (e.g., pain medications or sedatives), legally available substances such as alcohol or caffeine, or controlled or illicit drugs. Psychoactive substances can be used for medical, social, cultural, or recreational purposes, but some carry risks of misuse, dependence, and health or social harms when used in harmful ways.
European Drug Report 2023: Trends and Developments
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national...
Treatment and Prevention of Substance Use Disorders in the Workplace
ISSUP Kenya present their webinar on Workplace Substance Use.
Family Day: NGO launches an information guide for parents
A l’occasion de la journée internationale de la famille, célébrée le 15 mai de chaque année, l’ONG RAPAA (Recherche Action Prévention Accompagnement des Addictions) a organisé une cérémonie de lancement d’un guide destiné aux familles...
MPSP se manifesta contra a descriminalização do porte de drogas para consumo pessoal
Dr. Mario Luiz Sarrubbo, Procurador-Geral da Justiça do Estado de São Paulo, protocolizou um memorial no Supremo Tribunal Federal – STF com o posicionamento do Ministério Público paulista sobre a pauta que trata da possível...
Increase in driving after cocaine use in Spain: a cross-sectional dataset analysis for 2021
Objective: Driving under the influence of alcohol and/or drugs impairs skills essential for safe driving, increases the risk of being involved in a traffic accident and is particularly prevalent in Spain. The aim is to assess the prevalence...
Efectos del uso de cannabis fumada en adolescentes escolares
ISSUP Chile presentó un Webinar sobre 'Efectos del uso de cannabis fumada en adolescentes escolares'.
کاهش ننگ نسبت به افراد مبتلا به اچ آی وی و افرادی که مواد مخدر تزریق
با وجود شواهد گسترده در مورد اثرات منفی ننگ تجربه شده توسط افراد مبتلا به اچ آی وی (PLHIV) و افرادی که تزریق مواد مخدر در تنظیمات مراقبت های بهداشتی، شواهد نسبتا کمی در مورد اثر ابتکارات برای کاهش این ننگ وجود دارد.
نکات برجسته
- مداخلات...
مصرف مواد روانگردان در نمونه هایی از جمعیت مدارس گواتما
این تحقیق شامل 4 کار فارغ التحصیلی در کارشناسی ارشد، با روش توصیفی مخلوط، که با عوامل خطر مختلف است که باعث دانش آموزان در گوات مالا، که به مشکلات استفاده، مصرف و سوء استفاده از مواد سقوط انجام شد. این تحقیق اعضای جامعه آموزشی را از سطوح...
Treatment for drug and alcohol misuse should involve families and communities
Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant...
نوجوانان و مصرف مواد -- پدر و مادر چه کاری می تواند انجام دهد؟
هدف: کمک به بزرگسالان برای مدیریت خطرات مربوط به مصرف مواد نوجوانان در راستای اصول پیشگیری مبتنی بر شواهد.
سابقه و هدف: سیگار کشیدن و نوشیدن در میان دانش آموزان 15 تا 16 ساله نشان دهنده نشانه هایی از کاهش است، اما نگرانی هایی در مورد...
Understanding the risks of mixing drugs
February 17, 2022
Mixing drugs, also known as polysubstance use, occurs when two or more drugs are taken together or within a short time period, intentionally or unintentionally. Even if someone has mixed drugs before, or mixes drugs often...
Polysubstance Use Facts
What is polysubstance use?
The use of more than one drug, also known as polysubstance use, is common. This includes when two or more are taken together or within a short time period, either intentionally or unintentionally.
Intentional...
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Abstract
Substance use disorders (SUDs) are highly prevalent and impact individuals' health, well-being, and social functioning. Long-lasting changes in brain networks involved in reward, executive function, stress reactivity, mood, and...
استراتژی برای رسیدگی به کوکائین و مت آمفتمین
ارائه شده توسط ریچارد راوسون، دکترا، استاد برجسته در گروه روانپزشکی و علوم رفتاری زیستی، دانشکده پزشکی دانشگاه کالیفرنیا و استاد تحقیقات در دانشگاه ورمانت، این ارائه ارائه یک مرور کلی از دانش فعلی در مورد مشکل استفاده از محرک (کوکائین و مت...
UNODC supported delegations from four Central Asian countries in a high-level study tour to the United Kingdom
The UNODC Regional Office for Central Asia (ROCA) together with the UNODC Prevention, Treatment and Rehabilitation Section (PTRS) organized a study tour for high-level representatives, including senior officials, policymakers and substance...
72º Regular Session of the Inter-American Drug Abuse Control Comission was held
In the magazine CIJ Informa, the participation of CIJ, host chapter institution of ISSUP Mexico, in the 71st Regular Session of CICAD is reviewed.
The Anti-Stigma Network
The Anti-Stigma Network has been launched!
The Mission
The Anti-Stigma Network has been created by a group of organisations coming together with a shared mission.
Collectively they aim to improve understanding of the stigma and...
Buprenorphine versus methadone for the treatment of opioid dependence
Summary
Background
Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and...
بررسی اقتصادی درمان فارماکوولوژی برای اختلال استفاده از مواد مخدر: مرور سیستماتیک ادبیات
آبستره
هدف
بحران استفاده از مواد مخدر فشار بر منابع در ایالات متحده و در سراسر جهان قرار می دهد. 3 داروی مورد تایید سازمان غذا و داروی آمریکا برای درمان اختلال مصرف مواد مخدر وجود دارد: متادن، بوپرنرفین، و نالترکسون آزاد شده تزریقی (XR...